Impact of enucleation on adult retinoblastoma survivors' quality of life: A qualitative study of survivors' perspectives.

Journal Article (Journal Article)

OBJECTIVES: Retinoblastoma is the most common primary intraocular tumor of childhood with >95% survival rates in the US. Traditional therapy for retinoblastoma often included enucleation (removal of the eye). While much is known about the visual, physical, and cognitive ramifications of enucleation, data are lacking about survivors' perception of how this treatment impacts overall quality of life. METHODS: Qualitative analysis of an open-ended response describing how much the removal of an eye had affected retinoblastoma survivors' lives and in what ways in free text, narrative form. RESULTS: Four hundred and four retinoblastoma survivors who had undergone enucleation (bilateral disease = 214; 52% female; mean age = 44, SD = 11) completed the survey. Survivors reported physical problems (n = 205, 50.7%), intrapersonal problems (n = 77, 19.1%), social and relational problems (n = 98, 24.3%), and affective problems (n = 34, 8.4%) at a mean of 42 years after diagnosis. Three key themes emerged from survivors' responses; specifically, they (1) continue to report physical and intrapersonal struggles with appearance and related self-consciousness due to appearance; (2) have multiple social and relational problems, with teasing and bullying being prominent problems; and (3) reported utilization of active coping strategies, including developing more acceptance and learning compensatory skills around activities of daily living. SIGNIFICANCE OF RESULTS: This study suggests that adult retinoblastoma survivors treated with enucleation continue to struggle with a unique set of psychosocial problems. Future interventions can be designed to teach survivors more active coping skills (e.g., for appearance-related issues, vision-related issues, and teasing/bullying) to optimize survivors' long-term quality of life.

Full Text

Duke Authors

Cited Authors

  • Banerjee, SC; Pottenger, E; Petriccione, M; Chou, JF; Ford, JS; Sklar, CA; Robison, LL; Kleinerman, RA; Oeffinger, KC; Francis, JH; Abramson, DH; Dunkel, IJ; Friedman, DN

Published Date

  • June 2020

Published In

Volume / Issue

  • 18 / 3

Start / End Page

  • 322 - 331

PubMed ID

  • 31699178

Pubmed Central ID

  • PMC7205583

Electronic International Standard Serial Number (EISSN)

  • 1478-9523

Digital Object Identifier (DOI)

  • 10.1017/S1478951519000920


  • eng

Conference Location

  • England